JAMP TOBRAMYCIN / DEXAMETHASONE DIN 02571226
Health Canada record
| Active ingredient(s) | TOBRAMYCIN 0.3 %; DEXAMETHASONE 0.1 % |
|---|---|
| Dosage form | Suspension |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01CA01 DEXAMETHASONE AND ANTIINFECTIVES |
| Original market date | |
| Current status date | 01-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOBRAMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02241755 | SANDOZ TOBRAMYCIN | SANDOZ CANADA INCORPORATED | Solution | TOBRAMYCIN 0.3 % | Marketed |
| 02365154 | TOBI PODHALER | BGP PHARMA ULC | Capsule | TOBRAMYCIN 28 MG | Marketed |
| 00778915 | TOBRADEX | NOVARTIS PHARMACEUTICALS CANADA INC | Ointment | TOBRAMYCIN 0.3 %; DEXAMETHASONE 0.1 % | Marketed |
| 00778907 | TOBRADEX | NOVARTIS PHARMACEUTICALS CANADA INC | Suspension | TOBRAMYCIN 0.3 %; DEXAMETHASONE 0.1 % | Marketed |
| 00513962 | TOBREX | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | TOBRAMYCIN 0.3 % | Marketed |
| 00614254 | TOBREX | NOVARTIS PHARMACEUTICALS CANADA INC | Ointment | TOBRAMYCIN 0.3 % | Marketed |
| 02384930 | AJ-TOBRAMYCIN | AGILA JAMP CANADA INC | Liquid | TOBRAMYCIN 40 MG | Cancelled Pre Market |
| 02245698 | APO-TOBRAMYCIN | APOTEX INC | Solution | TOBRAMYCIN 0.3 % | Dormant |
| 02239577 | PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION | PHARMASCIENCE INC | Liquid | TOBRAMYCIN 3 MG | Cancelled Post Market |
| 02517825 | SANDOZ TOBRAMYCIN / DEXAMETHASONE | SANDOZ CANADA INCORPORATED | Suspension | TOBRAMYCIN 0.3 %; DEXAMETHASONE 0.1 % | Cancelled Pre Market |
| 02517833 | SANDOZ TOBRAMYCIN / DEXAMETHASONE | SANDOZ CANADA INCORPORATED | Ointment | TOBRAMYCIN 0.3 %; DEXAMETHASONE 0.1 % | Cancelled Pre Market |
| 02382814 | TOBRAMYCIN INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | TOBRAMYCIN 40 MG | Cancelled Post Market |
| 02239148 | TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% | BAUSCH & LOMB PHARMACEUTICALS INC. | Liquid | TOBRAMYCIN 3 MG | Cancelled Post Market |
| 02261243 | TOBREXAN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | TOBRAMYCIN 0.3 % | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38207 | 2026-09-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for TOBRAMYCIN
2 valid EDQM Certificates of Suitability from 2 holders. 6 active FDA Drug Master Files.
Request a quote for JAMP TOBRAMYCIN / DEXAMETHASONE